Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Primärliteratur
Bertelli G, Gozza A, Forno GB, et al: Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13: 2851–2855, 1995.
Kappel B, Hindenburg AA, Taub RN: Treatment of anthracycline extravasation–a warning against the use of sodium bicarbonate. J Clin Oncol 5: 825–826, 1987.
Tsavaris NB, Karagiaouris P, Tzannou I, et al: Conservative approach to the treatment of chemotherapy-induced extravasation. J Dermatol Surg Oncol 16: 519–522, 1990.
Tsavaris NB, Komitsopoulou P, Karagiaouris P, et al: Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol 30: 330–333, 1992.
Dini D, Forno G, Gozza A, et al: Combined management in the treatment of epidoxorubicin extravasation: a case report. Support Care Cancer 3: 150152, 1995.
Sekundärliteratur
Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.
Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6. Auflage: 1–17, 1999.
Krämer I: Onkologische Pharmazie. In: Jaehde U, Radziwill R, Mühlebach S, et al (Hrsg) Lehrbuch der Klinischen Pharmazie. Wissenschaftliche Verlagsgesellschaft mbH, 1. Auflage: 268–269, 1998.
Gain M, Melzer S, Meyer-Jürshof A, et al: Allgemeiner Teil: Behandlung von Paravasaten. In: Gain M, et al (Hrsg) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 1, 2. Auflage: A42–44, 1997.
Dorr RT, Von Hoff DD: Drug monographs: epirubicin. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton Lange, 2nd edition: 434–439, 1994.
Stanley A: Managing complications of chemotherapy. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 3rd edition: 105–124, 1997.
Mullin S, Beckwith MC, Tyler LS: Prevention and management of antineoplastic extravasation injury. Hosp Pharm 35: 57–76, 2000.
Kraft A, Weinig S, Edinger M, et al: Anthrazyklin-Extravasate. Der Onkologe 6: 674–686, 2000.
Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.
Preuss P, Partoft S: Cytostatic extravasations. Ann Plast Surg 19: 323–327,1987.
Webster PJ, D’Souza D: Extravasation of epirubicin/vincristine and ifosfamide/ mesna from a central venous catheter. J Oncol Pharm Practice 1: 41–44, 1995.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Wien
About this chapter
Cite this chapter
Mader, I., Fürst-Weger, P., Mader, R.M., Semenitz, E.I., Terkola, R., Wassertheurer, S.M. (2002). Epirubicin. In: Paravasation von Zytostatika. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3799-4_24
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3799-4_24
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-3800-7
Online ISBN: 978-3-7091-3799-4
eBook Packages: Springer Book Archive